Breaking News
Outraged Farmers Blame Ag Monopolies as Catastrophic Collapse Looms
Exposing the Cover-Up That Could Collapse Big Medicine: Parasites
Israel's Former Space Security Chief says Aliens exist, and President Trump knows about it
Putin's advisor Kobyakov: The U.S. has devised a crypto scheme to erase its massive debt...
Top Tech News
Methylene chloride (CH2Cl?) and acetone (C?H?O) create a powerful paint remover...
Engineer Builds His Own X-Ray After Hospital Charges Him $69K
Researchers create 2D nanomaterials with up to nine metals for extreme conditions
The Evolution of Electric Motors: From Bulky to Lightweight, Efficient Powerhouses
3D-Printing 'Glue Gun' Can Repair Bone Fractures During Surgery Filling-in the Gaps Around..
Kevlar-like EV battery material dissolves after use to recycle itself
Laser connects plane and satellite in breakthrough air-to-space link
Lucid Motors' World-Leading Electric Powertrain Breakdown with Emad Dlala and Eric Bach
Murder, UFOs & Antigravity Tech -- What's Really Happening at Huntsville, Alabama's Space Po
Tiny briefcase engine boosts EV range beyond battery power 
Scientists Are Racing to Create Synthetic Blood in the Wake of Mass Tragedies
The Las Vegas shooting is the latest reminder that human blood isn't enough for massive, unexpected transfusions.
In the aftermath of the Las Vegas mass shooting on Sunday, hundreds of people lined up to give blood at a handful of donation centers in the area. It was a heartening scene—people hoping to help in any way they could. But if science lives out its promise, it will one day be an obsolete one.
Scientists have been working on creating synthetic blood for years now. The hope is that this substance will have a longer shelf life than human blood—which can only be refrigerated for 42 days—and eventually can be packaged and stored for use in emergencies. If this works, thousands of lives could be saved every year.
"People can't show up fast enough and then the system can't draw their blood fast enough to meet the need," said Allan Doctor, a physician and researcher at the Washington University in St. Louis. "Pulse nightclub, Boston Marathon, now Vegas—all of these are situations where there's a sudden unpredictable need for massive transfusion."
Doctor's lab has been working to create a blood substitute called ErythroMer, comprised of human hemoglobin, sourced from the red blood cells in expired blood at blood banks, and a synthetic polymer. This synthetic blood is actually a dehydrated powder, which would allow it to be stored for years, rather than weeks, and easily transported. Doctor envisions that it could eventually be packaged along with purified water so that doctors or EMTs could mix it when they needed to use it on a patient.
ErythroMer is still in the planning stages. It has only been tested on animals, and Doctor predicts that the team is about three to five years from the first human trials. Following that, it will need FDA approval, and then healthcare workers will need to be trained to use it properly to avoid infections. "It's important for us to have a bulletproof delivery system," Doctor told me. He predicts that it will be available in six to 10 years if the trials are successful, and if they can make a cost-effective formula.